Kristina Striepe
Friedrich-Alexander-Universität Erlangen-Nürnberg(DE)Universitätsklinikum Erlangen(DE)Comprehensive Cancer Center Erlangen(DE)
Publications by Year
Research Areas
Diabetes Treatment and Management, Blood Pressure and Hypertension Studies, Cardiovascular Health and Disease Prevention, Cardiovascular Function and Risk Factors, Noise Effects and Management
Most-Cited Works
- → SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial(2018)180 cited
- → Effects of the Selective Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin on Vascular Function and Central Hemodynamics in Patients With Type 2 Diabetes Mellitus(2017)176 cited
- → A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation(2017)146 cited
- → How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial(2019)118 cited
- → Effect of empagliflozin on ketone bodies in patients with stable chronic heart failure(2021)65 cited
- → Effects of manidipine vs. amlodipine on intrarenal haemodynamics in patients with arterial hypertension(2012)29 cited